Home      About this journal      Authors      Editors      Readers      Archive      Contact us
Efficacy and mechanism of Jianpi Lishi decoction in the treatment of patients with mild to moderate ulcerative colitis by regulating the function of Treg cells
Hits 1490  Download times 1377  Received:December 10, 2017  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1672-1519.2018.05.07
Key Words   ulcerative colitis;regulatory T cells;perforin;granzyme B
Author NameAffiliation
HAO Lili Department of Spleen and Stomach Diseases, The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China 
LIU Xiaoxi Department of Spleen and Stomach Diseases, The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China 
Abstract
    [Objective] In this study, the clinical efficacy of Jianpi Lishi decoction on mild to moderate ulcerative colitis (UC) and mechanisms associated with the function of Tregs were investigated.[Methods] Altogether 59 patients with mild to moderate UC were enrolled and randomly allocated to the control and Jianpi Lishi groups. The control group received salbutamol enteric-coated tablets, and the Jianpi Lishi group was given Jianpi Lishi decoction orally. The treatment process would be lasted for 3 months. The main symptom scores, curative effect index and the quality of life of patients were observed before and after treatment. The concentrations of IL-1β and TGF-β1 in peripheral blood were measured by enzyme-linked immunosorbent assay (ELISA) and the mRNA levels of Foxp3, perforin and granzyme B were determined by RT-qPCR.[Results] After treatment, the above symptoms were improved significantly, and the effect of "Jianpi Lishi" group was much better than that of the control group (P<0.05). After 3 months of treatment, the quality of life in gastrointestinal symptoms, systemic symptoms, affective ability and social ability of the two groups were significantly higher than those before treatment (P<0.05), and the quality of life was significantly better in the Jianpi Lishi group when compared with the control group (P<0.05). Compared with normal subjects, the levels of IL-1β in peripheral blood were higher in the two groups before treatment, while the level of TGF-β was lower; the mRNA level of Foxp3 was lower, and the mRNA levels of perforin and granzyme B were higher (P<0.05 or P<0.01). After treatment, the levels of above-mentioned cytokines and genes were changed to the opposite direction with significant differences (P<0.05 or P<0.01), and the improvement effect of Jianpi Lishi group was more obvious than the control group (P<0.05).[Conclusion] Jianpi Lishi decoction can enhance the immunosuppressive function by regulating the number and function of Tregs, and inhibit the killing effect of perforin/granzyme B on target cells, so as to reduce the inflammatory reaction of intestinal tract.

You are the 2306359 visitor.

Copyright @ 2007
Address: 10 Boyanghu Road, West District of Tuanbo New City, Jinghai District, Tianjin 301617, China  Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.